However, it is still unclear whether CD34+ cells exhibit altered differentiation potential in the metabolic microenvironment (especially in lipid metabolism disorders) under conditions of hypertension and hyperlipidemia and whether CD34+ cells play a role in cardiac fibrosis. This evidence concerns the gene CD34 and Hypertension.